EAST RUTHERFORD, N.J., October 17, 2024 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that its stability storage business, Q1 Scientific, has opened a new cGMP facility in Durham, North Carolinaexpanding its capacity for environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries in North America.
Q1 Scientific, a Cambrex Company Logo
Strategically located in the Research Triangle Park region, the new state-of-the-art temperature-controlled and monitored storage facility offers 7 ICH stability chambers, covering a variety of conditions including 2-8°C, 25°C/60 %RH, 30°C/65%RH, 30°C/75%RH and 40°C/75%RH, as well as -20°C and ultra-low (-70°C/-80°C) storage conditions ). The facility’s location at Research Triangle Park (RTP) in North Carolina will provide same day and next day delivery throughout the United States.
Tom LoewaldCEO of Cambrex, said: “After acquiring Q1 Scientific in 2022, we have strategically expanded our presence to offer the best service to our customers around the world. This first facility opening in North America marks an important milestone in Q1’s growth. “Scientific”.
Q1 Scientific’s expansion complements its existing facilities in WaterfordIreland and Liège, Belgium, and is located within Cambrex’s existing analytical services site in Durham.
Stephen DelaneyCEO of Q1 Scientific, added: “With the capabilities and expertise located in Durham, we can now offer services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products.”
Cambrex continues to expand its capabilities and potential in its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) providing drug substance development and manufacturing across their entire life cycle, as well as comprehensive IND clearance and testing services.
With more than 40 years of experience and a team of 2,000 experts serving global clients in North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid state science, characterization of highly powerful materials and APIs.
About Q1 Scientific, a Cambrex Company
Q1 Scientific, a Cambrex company, is a leading provider of environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries. With a decade of experience, Q1 Scientific safeguards critical breakthroughs and life-changing innovations in state-of-the-art facilities in Ireland and Belgium. By utilizing Q1 Scientific’s services, companies can accelerate the introduction of new drugs to market while avoiding the expense of building and monitoring their own storage chambers. In June 2022, Q1 Scientific was acquired by Cambrex.
Logo – https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Logo –
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
